DonateNow
Print this Article

PI Perspective 24: Drug Identification Chart


Project Inform - April, 1998


Protease Inhibitors
Initials Generic name Trade name Manufacturer
AMP amprenavir n/a Glaxo Wellcome
IDV indinavir Crixivan© Merck
NFV nelfinavir Viracept© Agouron
SQVhgc saquinavir Invirase© Hoffman-La Roche
SQVsgc
soft gel capsule
saquinavir (new) Fortovase© Hoffman-La Roche
RTV ritonavir Norvir© Abbott Labs
NARTIs (Nucleoside Analogue Reverse Transcriptase Inhibitors)
Initials Generic name Trade name Manufacturer
ABA abacavir Ziagen© Glaxo Wellcome
ADF adefovir Preveon© Gilead Sciences
AZT zidovudine Retrovir© Glaxo Wellcome
ddC zalcitabine Hivid© Hoffman-La Roche
ddI didanosine Videx© Bristol-Myers Squibb
d4T stavudine Zerit© Bristol-Myers Squibb
3TC lamivudine Epivir© Glaxo Wellcome
ATZ+3TC n/a Combivir© Glaxo Wellcome
NNRTIs (Non-Nucleoside Reverse Transcriptase Inhibitors)
Initials Generic name Trade name Manufacturer
EFV efavirenz Sustiva© Dupont Merck
NVP nevirapine Viramune© Boehringer Ingelheim
DLV delavirdine Rescriptor© Pharmacia & Upjohn

980401
PI980408


Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

©1998. This document is copyrighted by Project Inform, 205 13th Street, #2001, San Francisco, CA 94103. Treatment Hotline: 800-822-7422 (toll-free) or 415-558-9051 (in the San Francisco Bay Area and internationally) All Project Inform materials may be reprinted and/or distributed without prior permission. However, reprints may not be edited and must include the following text: "From Project Inform, for more information contact the Project Inform National HIV/AIDS Treatment Hotline, 800-822-7422." For permission to edit any Project Inform material for further publication, contact David Evans at the Project Inform office.

Project Inform, established in 1985 as a national, non profit, community-based HIV/AIDS treatment information and advocacy organization, serves HIV-infected individuals, their care-givers, and their healthcare and service providers through its national, toll-free treatment hotline, the PI Perspective and other information publications, educational Town Meetings, on-line services and research and drug access advocacy programs. All information is available free of charge; donations are strongly encouraged. For more information, contact the Project Inform National HIV/AIDS Treatment Hotline. Email: web@projinf.org; Website: http://www.projinf.org.

The original of this article can be found at http://www.projinf.org/pub/24/lowerdose.html


This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1998. AEGiS.